Joe Bernardo

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE.

BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE.

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE.

Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland.

BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE.